来自MSN1 天
Scientists Design Ultra-Stable Synthetic Proteins That Could Change Drug Discovery
Innovative designs of GPCRs with enhanced signaling and stability offer new insights for drug discovery and synthetic biology ...
News Medical3 天
Study could help predict treatment response for KRASG12C-mutant non-small cell lung cancer
A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will respond to new therapies.
Armed robbery in Revesby3 天
Key Biomarker Predicts KRASG12C Inhibitor in Lung Cancer
A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will respond to new ...
technologynetworks4 天
Improving Efficiency in Drug Discovery and Development
This article explores methods to enhance efficiency in the drug discovery and development pipeline, focusing on optimizing processes and exploring innovations that could streamline the path from ...
EurekAlert!4 天
Moffitt study finds key biomarker to predict KRASG12C inhibitor effectiveness in lung cancer
A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will respond to new therapies. The research, published in Clinical Cancer ...